tiprankstipranks
Advertisement
Advertisement
Simcere to Acquire Related Diagnostics Firm in RMB30.76 Million Connected Deal
PremiumCompany AnnouncementsSimcere to Acquire Related Diagnostics Firm in RMB30.76 Million Connected Deal
14d ago
Simcere Pharma Reshapes Corporate Secretariat With New Joint Company Secretary
Premium
Company Announcements
Simcere Pharma Reshapes Corporate Secretariat With New Joint Company Secretary
14d ago
Simcere Showcases Promising Bladder Cancer Data for Novel Immunotherapy SIM0237
Premium
Company Announcements
Simcere Showcases Promising Bladder Cancer Data for Novel Immunotherapy SIM0237
22d ago
Simcere Plans HK Spin-off Listing for Oncology Unit Simcere Zaiming
PremiumCompany AnnouncementsSimcere Plans HK Spin-off Listing for Oncology Unit Simcere Zaiming
3M ago
Simcere Wins NMPA Nod to Start Clinical Trials for Novel EGFR/cMET Cancer Drug
Premium
Company Announcements
Simcere Wins NMPA Nod to Start Clinical Trials for Novel EGFR/cMET Cancer Drug
4M ago
Simcere Licenses Global Rights to Cancer ADC SIM0613 to Ipsen in US$1.06 Billion Deal
Premium
Company Announcements
Simcere Licenses Global Rights to Cancer ADC SIM0613 to Ipsen in US$1.06 Billion Deal
4M ago
Simcere Pharmaceutical Expands Through Strategic Acquisitions
PremiumCompany AnnouncementsSimcere Pharmaceutical Expands Through Strategic Acquisitions
7M ago
Simcere Pharmaceutical Completes Share Placement and Subscription to Boost R&D
Premium
Company Announcements
Simcere Pharmaceutical Completes Share Placement and Subscription to Boost R&D
7M ago
Simcere Pharmaceutical’s SIM0609 Receives Clinical Trial Approval
Premium
Company Announcements
Simcere Pharmaceutical’s SIM0609 Receives Clinical Trial Approval
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100